Published in Reproduction on February 25, 2010
Protein phosphatases decrease their activity during capacitation: a new requirement for this event. PLoS One (2013) 0.91
Proteomic analyses reveal a role of cytoplasmic droplets as an energy source during epididymal sperm maturation. PLoS One (2013) 0.80
Estrogen suppresses melatonin-enhanced hyperactivation of hamster spermatozoa. J Reprod Dev (2015) 0.78
The increase in phosphorylation levels of serine residues of protein HSP70 during holding time at 17°C is concomitant with a higher cryotolerance of boar spermatozoa. PLoS One (2014) 0.76
Factors and pathways involved in capacitation: how are they regulated? Oncotarget (2016) 0.75
Changes in Carboxy Methylation and Tyrosine Phosphorylation of Protein Phosphatase PP2A Are Associated with Epididymal Sperm Maturation and Motility. PLoS One (2015) 0.75
Important surgical measures and techniques at cesarean hysterectomy for placenta previa accreta. Acta Obstet Gynecol Scand (2013) 3.91
Threshold of soluble fms-like tyrosine kinase 1/placental growth factor ratio for the imminent onset of preeclampsia. Hypertension (2011) 1.65
Gene expression profile for predicting survival in advanced-stage serous ovarian cancer across two independent datasets. PLoS One (2010) 1.58
MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma. Clin Cancer Res (2006) 1.46
Radiation therapy for chemotherapy-resistant recurrent epithelial ovarian cancer. Oncology (2014) 1.40
Anterior placentation as a risk factor for massive hemorrhage during cesarean section in patients with placenta previa. J Obstet Gynaecol Res (2014) 1.39
Ovarian metastasis in carcinoma of the uterine cervix. Gynecol Oncol (2005) 1.24
Effect of recombinant placental growth factor 2 on hypertension induced by full-length mouse soluble fms-like tyrosine kinase 1 adenoviral vector in pregnant mice. Hypertension (2009) 1.19
Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary. Obstet Gynecol (2002) 1.18
Vaginal lactobacilli and preterm birth. J Perinat Med (2002) 1.15
Onset threshold of the plasma levels of soluble fms-like tyrosine kinase 1/placental growth factor ratio for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19-31 weeks of gestation. Hypertens Res (2013) 1.13
Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis. Cancer Sci (2009) 1.12
Inhibition of tumor invasion by genomic down-regulation of matriptase through suppression of activation of receptor-bound pro-urokinase. J Biol Chem (2004) 1.10
Clinicopathological characteristics of mucinous adenocarcinoma of the ovary. Gynecol Oncol (2009) 1.07
Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia. Hypertens Res (2007) 1.06
Glutathione peroxidase 3 is a candidate mechanism of anticancer drug resistance of ovarian clear cell adenocarcinoma. Oncol Rep (2008) 1.03
Sexually dimorphic expression of the novel germ cell antigen TEX101 during mouse gonad development. Biol Reprod (2005) 1.03
Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis. Mol Cancer Res (2012) 1.03
Interleukin-10-mediated inhibition of angiogenesis and tumor growth in mice bearing VEGF-producing ovarian cancer. Cancer Res (2003) 1.02
Femur fracture during abdominal breech delivery. Arch Gynecol Obstet (2008) 1.02
Non-traumatic rupture of the left upper urinary tract during pregnancy without discernable underlying disorders. Arch Gynecol Obstet (2009) 1.02
Adjuvant chemotherapy with irinotecan hydrochloride and cisplatin for clear cell carcinoma of the ovary. Oncol Rep (2006) 1.01
Uterine compression sutures for postpartum hemorrhage: an overview. Acta Obstet Gynecol Scand (2013) 1.00
Asymptomatic uterine artery pseudoaneurysm after cesarean section. J Obstet Gynaecol Res (2010) 1.00
Indoleamine 2,3-dioxygenase promotes peritoneal dissemination of ovarian cancer through inhibition of natural killercell function and angiogenesis promotion. Int J Oncol (2011) 0.98
Effect of maternal age on blood loss during parturition: a retrospective multivariate analysis of 10,053 cases. J Perinat Med (2003) 0.98
A randomized Phase II/III trial of 3 weekly intraperitoneal versus intravenous carboplatin in combination with intravenous weekly dose-dense paclitaxel for newly diagnosed ovarian, fallopian tube and primary peritoneal cancer. Jpn J Clin Oncol (2010) 0.98
TEX101 is shed from the surface of sperm located in the caput epididymidis of the mouse. Zygote (2005) 0.97
Decidualization of ovarian endometriosis during pregnancy mimicking malignancy: report of three cases with a literature review. Gynecol Obstet Invest (2008) 0.96
Inhibition of peritoneal dissemination of ovarian cancer by tyrosine kinase receptor inhibitor SU6668 (TSU-68). Int J Cancer (2005) 0.96
Mirror syndrome associated with hydropic acardius in triplet pregnancy. Fetal Diagn Ther (2008) 0.95
Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia. Hypertens Res (2010) 0.93
Suppression of cell migration in ovarian cancer cells mediated by PTEN overexpression. Int J Oncol (2003) 0.91
PTEN expression is associated with prognosis for patients with advanced endometrial carcinoma undergoing postoperative chemotherapy. Int J Cancer (2002) 0.90
Normal and high-normal blood pressures, but not body mass index, are risk factors for the subsequent occurrence of both preeclampsia and gestational hypertension: a retrospective cohort study. Hypertens Res (2006) 0.90
Indoleamine-2,3-dioxygenase, an immunosuppressive enzyme that inhibits natural killer cell function, as a useful target for ovarian cancer therapy. Int J Oncol (2011) 0.90
Development of a mouse model for lymph node metastasis with endometrial cancer. Cancer Sci (2011) 0.90
Is peritoneal cytology a prognostic factor of endometrial cancer confined to the uterus? Gynecol Oncol (2006) 0.89
Mechanisms of cisplatin resistance in clear cell carcinoma of the ovary. Oncology (2002) 0.89
In vivo delivery of siRNA targeting vasohibin-2 decreases tumor angiogenesis and suppresses tumor growth in ovarian cancer. Cancer Sci (2013) 0.89
Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis. Int J Clin Oncol (2007) 0.89
Connection between hyperemesis gravidarum, jaundice or liver dysfunction, and biliary sludge. J Obstet Gynaecol Res (2012) 0.89
Alteration of serum soluble endoglin levels after the onset of preeclampsia is more pronounced in women with early-onset. Hypertens Res (2008) 0.88
The impact of complete surgical staging upon survival in early-stage ovarian clear cell carcinoma: a multi-institutional retrospective study. Int J Gynecol Cancer (2009) 0.88
Establishing reference values for both total soluble Fms-like tyrosine kinase 1 and free placental growth factor in pregnant women. Hypertens Res (2005) 0.88
Gestational hypertension as a subclinical preeclampsia in view of serum levels of angiogenesis-related factors. Hypertens Res (2010) 0.88
Overexpression of PTEN increases sensitivity to SN-38, an active metabolite of the topoisomerase I inhibitor irinotecan, in ovarian cancer cells. Clin Cancer Res (2002) 0.87
Guidelines for office gynecology in Japan: Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists 2011 edition. J Obstet Gynaecol Res (2012) 0.87
Gene expression profiling of the rat endometriosis model. Am J Reprod Immunol (2007) 0.86
Depot-specific expression of lipolytic genes in human adipose tissues--association among CES1 expression, triglyceride lipase activity and adiposity. J Atheroscler Thromb (2010) 0.86
Smooth muscle metaplasia and innervation in interstitium of endometriotic lesions related to pain. Fertil Steril (2008) 0.86
Evaluation of human epididymis protein 4 (HE4) and Risk of Ovarian Malignancy Algorithm (ROMA) as diagnostic tools of type I and type II epithelial ovarian cancer in Japanese women. Tumour Biol (2014) 0.86
Uterine artery pseudoaneurysm: not a rare condition occurring after non-traumatic delivery or non-traumatic abortion. Arch Gynecol Obstet (2014) 0.85
Manual separation followed by local cleanliness for pediatric labial adhesion. J Obstet Gynaecol Res (2010) 0.85
Fetal heart rate pattern reflecting the severity of placental abruption. Arch Gynecol Obstet (2007) 0.85
Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin. Int J Cancer (2003) 0.85
Live births from isolated primary/early secondary follicles following a multistep culture without organ culture in mice. Reproduction (2013) 0.85
Prediction of pregnancy by intrauterine insemination using CASA estimates and strict criteria in patients with male factor infertility. Int J Androl (2004) 0.85
An improbable monometallic cluster entrapped in a popular fullerene cage: YCN@C(s)(6)-C82. Sci Rep (2013) 0.84
Screening for genetic abnormalities involved in ovarian carcinogenesis using retroviral expression libraries. Int J Oncol (2009) 0.84
Comparison of the Sperm Quality Analyzer IIC variables with the computer-aided sperm analysis estimates. Int J Androl (2002) 0.84
Bikunin target genes in ovarian cancer cells identified by microarray analysis. J Biol Chem (2003) 0.84
Mutational analysis of TP53 and p21 in familial and sporadic ovarian cancer in Japan. Gynecol Oncol (2005) 0.84
A feasibility study of paclitaxel and carboplatin therapy in Japanese patients with epithelial ovarian cancer. Oncol Rep (2003) 0.84
Thymidine phosphorylase expression in tumor-infiltrating macrophages may be correlated with poor prognosis in uterine endometrial cancer. Hum Pathol (2002) 0.84
Overexpression of PTEN in ovarian cancer cells suppresses i.p. dissemination and extends survival in mice. Mol Cancer Ther (2008) 0.84
Pregnancy complicated with Alport syndrome: a good obstetric outcome and failure to diagnose an infant born to a mother with Alport syndrome by umbilical cord immunofluorescence staining. J Obstet Gynaecol Res (2009) 0.83
Cetuximab inhibits growth, peritoneal dissemination, and lymph node and lung metastasis of endometrial cancer, and prolongs host survival. Int J Oncol (2009) 0.83
Serum sFlt1:PlGF ratio, PlGF, and soluble endoglin levels in gestational proteinuria. Hypertens Pregnancy (2009) 0.83
Applicability of the concept of "platinum sensitivity" to recurrent endometrial cancer: the SGSG-012/GOTIC-004/Intergroup study. Gynecol Oncol (2013) 0.82
Oral eicosapentaenoic acid supplementation as possible therapy for endometriosis. Fertil Steril (2007) 0.82
Suppression of ovarian cancer by muscle-mediated expression of soluble VEGFR-1/Flt-1 using adeno-associated virus serotype 1-derived vector. Int J Cancer (2007) 0.82
Cetuximab inhibits the growth of mucinous ovarian carcinoma tumor cells lacking KRAS gene mutations. Oncol Rep (2012) 0.82
Establishing a reference value for the frequency of fetal movements using modified 'count to 10' method. J Obstet Gynaecol Res (2008) 0.82
Overexpression of thymidylate synthase mediates desensitization for 5-fluorouracil of tumor cells. Int J Cancer (2003) 0.82
Enhanced expression of thymidylate synthase mediates resistance of uterine cervical cancer cells to radiation. Oncology (2002) 0.82
Downregulation of indoleamine-2,3-dioxygenase in cervical cancer cells suppresses tumor growth by promoting natural killer cell accumulation. Oncol Rep (2012) 0.82
Antinuclear antibody reduces the pregnancy rate in the first IVF-ET treatment cycle but not the cumulative pregnancy rate without specific medication. Am J Reprod Immunol (2003) 0.81
Upregulation of bikunin in tumor-infiltrating macrophages as a factor of favorable prognosis in ovarian cancer. Gynecol Oncol (2004) 0.81
Hydrocephalus after intraventricular hemorrhage in eclamptic woman with HELLP syndrome. Hypertens Pregnancy (2006) 0.81
Fertility-sparing treatment using medroxyprogesterone acetate for endometrial carcinoma. Oncol Lett (2012) 0.81
A novel method for evaluating uterine cervical consistency using vaginal ultrasound gray-level histogram. J Perinat Med (2010) 0.81
The effect of single weekly paclitaxel in heavily pretreated patients with recurrent or persistent advanced ovarian cancer. Gynecol Oncol (2004) 0.81
Prediction of individual response to platinum/paclitaxel combination using novel marker genes in ovarian cancers. Mol Cancer Ther (2006) 0.81
Phase I study of combination chemotherapy using irinotecan hydrochloride and nedaplatin for advanced or recurrent cervical cancer. Oncology (2003) 0.81
Aberrant expression of pyloric gland-type mucin in mucin-producing bile duct carcinomas: a clear difference between the core peptide and the carbohydrate moiety. Pathol Int (2005) 0.81
Acute promyelocytic leukemia: an unusual cause showing prolonged disseminated intravascular coagulation after placental abruption. Arch Gynecol Obstet (2007) 0.81
Major complications and outcome of diagnostic and operative transvaginal hydrolaparoscopy. J Obstet Gynaecol Res (2007) 0.81
Downregulation of vasohibin-2, a novel angiogenesis regulator, suppresses tumor growth by inhibiting angiogenesis in endometrial cancer cells. Oncol Lett (2013) 0.81
[An autopsy of G-CSF-producing anaplastic carcinoma of the pancreas with impaired accumulation on FDG-PET after S-1 chemotherapy]. Gan To Kagaku Ryoho (2013) 0.80
Uterine compression suture against impending recurrence of uterine inversion immediately after laparotomy repositioning. J Obstet Gynaecol Res (2009) 0.80
Uterine artery pseudoaneurysm manifesting as postpartum hemorrhage after uneventful second-trimester pregnancy termination. J Obstet Gynaecol Res (2010) 0.80
Thin anterior uterine wall with incomplete uterine rupture in a primigravida detected by palpation and ultrasound: a case report. J Med Case Rep (2011) 0.80
Maternal rib fracture after manual uterine fundal pressure. Rural Remote Health (2012) 0.80
3D color Doppler of monoamniotic twin cord entanglement. Arch Gynecol Obstet (2009) 0.80
Reduced bikunin gene expression as a factor of poor prognosis in ovarian carcinoma. Cancer (2003) 0.80
Establishing reference values for mean notch depth index, pulsatility index and resistance index in the uterine artery at 16-23 weeks' gestation. J Obstet Gynaecol Res (2012) 0.80
C-reactive protein levels at pre-/post-indicated cervical cerclage predict very preterm birth. J Perinat Med (2011) 0.80
Analysis of factors associated with multinucleate formation in human IVF. Int J Androl (2003) 0.80